James F. Oliviero III - 31 Dec 2022 Form 5 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
CEO, President and Director, Director
Signature
/s/ James F. Oliviero, III
Issuer symbol
CKPT
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
12 Jan 2023, 19:00:32 UTC
Previous filing
01 Jul 2022
Next filing
12 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT Common Stock Gift $0 -60,000 -23% $0.000000 196,199 26 Sep 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 26, 2022, shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust.
F2 Checkpoint Therapeutics, Inc. effected a reverse stock split on December 6, 2022. The reported number gives effect to this reverse stock split.
F3 Includes shares of restricted common stock, which vest over various time periods.